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Abstract
Primary hepatic carcinoid tumor is rare and poses a challenge for diagnosis and management. We presented a
case of primary hepatic carcinoid tumor in a 53-year-old female with a complaint of right upper abdominal pain.
Computer tomography scans revealed a hypervascular mass in segment 4 of the liver. An ultrasonography-guided
biopsy showed a carcinoid tumor. No other lesions were found by the radiological investigations. Surgery resection
was performed and histopathological examination revealed a primary hepatic carcinoid tumor. Three years later,
recurrence was found and transcatheter arterial chemoembolization was performed. After transcatheter arterial
chemoembolization, the patient has been free of symptom and had no radiological disease progression for over 6
months. Surgical resection combination with transcatheter arterial chemoembolization is effective to offer excellent
palliation.
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Background
Carcinoid tumors are neoplasms that originate from the
cells of neuroendocrine system, and were first character-
ized by Oberndorfer in 1907. They are usually low-grade
malignant tumors that may cause the carcinoid syndrome
by secretion of serotonin and other vasoactive hormones.
Most of them occur within the gastrointestinal tract, pri-
marily in the appendix and the terminal ileum [1,2]. Pri-
mary hepatic carcinoid tumors (PHCT) are very rare.
Here, we report a case of PHCT, and describe the clinical
features and treatment of this case.
Case report
A 53-year-old female presented with right upper quadrant
abdominal pain and was admitted to our hospital in May
2007. The patient had no history of jaundice, vomiting,
flushing or diarrhea. Her past medical history included
hypertension and a cholecystectomy due to gallstones 10
years previously. Physical examination showed no
abnormality except for the presence of a scar in the right
upper quadrant of abdomen. Laboratory investigations,
including liver function test, renal function test, blood rou-
tine test and tumor markers (AFP, CEA, CA19-9, CA242,
CA125 and CA15-3), were within normal limits. Serum
hepatitis B surface antigen and hepatitis C antibody were
negative.
Computer tomography (CT) revealed a low density
nodule in segment 4 of liver. Dynamic CT scans showed
e n h a n c e do ft h en o d u l ei nt h ea r t e r i a lp h a s ea n de a r l y
washout in the portal phase (Figure 1). Liver ultrasound
confirmed the presence of the hypervascular mass. No
enlarged lymph nodes were found by CT or ultrasonic.
Based on the imaging finding, hepatocelluar carcinoma
was highly suspected. A fine-needle aspiration biopsy was
performed under ultrasonographic guidance for definite
diagnosis. The histological examination of the biopsy spe-
cimens suggested the tumor was a carcinoid tumor. The
neoplastic cells were round or columnar cells with round
nuclei and pale eosinophilic cytoplasm. Immunohisto-
chemistry was positive for pancytokeratin AE1/AE3,
synaptophysin and chromorgranin A. There was negative
staining for AFP, hepatocyte, CK-7, CK-20 and villin
(Figure 2). To rule out the possibility of metastatic carci-
noid tumor in the liver, more investigations were per-
formed, including upper and lower gastrointestinal series,
a small bowel series and chest and abdominal CT scans.
All these investigations were negative.
In May 2007, left hepatectomy was carried out. No
asites was noted and the liver was not cirrhotic. Exten-
sive abdominal exploration showed no any other site of
primary tumor. The operation was performed success-
fully and the postoperative recovery was uneventful.
The resected liver specimen contained a 4.0 cm tumor.
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confirmed the findings of the biopsy and the resection
line was free from tumor invasion.
At three years after operation, MRI showed multiple
lesions of the liver. No other lesions were found by the
radiological investigations which include upper gastroin-
testinal endoscopy, a small bowel series, colonoscopy,
chest CT and abdominal CT scans. The recurrence of
carcinoid tumor was highly suspected. Due to the multi-
ple lesion of the liver, resection was not feasible and 4
times of transcatheter arterial chemoembolization
(TACE, consisting of 0.75 g 5-Fu, 20 mg adriamycin, 8
ml lipiodol and spongel) was performed. Six months after
the last TACE, the patient was free of symptom and had
no radiological disease progression.
Discussion
Carcinoid tumors are defined as neuroendocrine tumor.
The origin of primary hepatic carcinoid tumors is not
well known. They may arise from scatter neuroendocrine
cells in the intrahepatic biliary epithelium. It is also
hypothesized that chronic inflammation in biliary system
may initiate intestinal metaplasia, which predisposes to
the development of neuroendocrine tumors. Another
possibility is that they originate from ectopic pancreatic
or adrenal tissues found within the liver [3].
PHCT are very rare. There are only about 94 cases
reported in the current literature [4]. PHCT occur
mainly in middle age and is slightly more frequent in
females (58.5%). The symptoms of PHCT are non-speci-
fic, such as abdominal pain, abdominal mass, fatigue,
and weight loss. More than 10% cases are asymptomatic.
Only a small percent of patients present the typical car-
cinoid syndrome (skin flushing, abdominal pain and
diarrhea) [4]. The case we presented was a 53-year-old
female suffered with right upper quadrant abdominal
pain.
Ultrasound is an inexpensive and easily available ima-
ging test for evaluation of liver lesions. Solid masses
with cystic areas and hyperechoic or mixed pattern
are common findings of PHCT detected by ultrasonic.
C o n t r a s t - e n h a n c e dU Ss h o w e dar a p i da n dd e n s e
Figure 1 Computed tomography (CT) of the liver. A. Noncontrast CT image shows a low density mass in segment 4 of liver. B, C. Dynamic
CT scans show enhanced of the nodule in the arterial phase and early washout in the portal phase.
Figure 2 Histological findings of the liver tumor. A. Histological examination showed that the tumor cells were round or columnar cells with
round nuclei and pale eosinophilic cytoplasm (HE, ×400). B. Immunohistochemistry revealed the tumor cells were positive for synaptophysin
(×400). C. Immunohistochemistry revealed the tumor cells were positive for chromorgranin A. (×400).
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ing CT findings in PHCT, in most cases noncontrast
images show low-density masses, and some have cystic
component. Dynamic contrast CT shows enhanced
masses in the early phase and low density masses in the
late phase [7]. On MRI PHCT usually present with low
intensity in T1-weighted images and high intensity on
T2-weighted images. Angiography revealed hypervascu-
lar masses with or without staining in most cases [8]. In
radiological examination, PHCT are detected as hyper-
vascular solid masses with or without cystic areas.
The diagnosis of hepatic carcinoid tumor is mainly
based on histological and immunohistochemistry exami-
nation. In our case, histological examination of the biopsy
specimen and the resected specimen revealed that the
tumor cells were round or columnar cells with round
nuclei and pale eosinophilic cytoplasm. In immunohisto-
chemistry these cells showed positive for the neuroendo-
crine markers synaptophysin and chromorgranin A. The
differentiation between primary and secondary hepatic
carcinoid tumor is impossible identified by histology
alone. Because liver is a common site for carcinoid metas-
tasis, the diagnosis of PHCT requires intensive preopera-
tive imaging, operative inspection and long-term follow-
up. In our case, the patient was followed up for about
4 years after resection. Any other extrahepatic lesion was
not found radiologically during follow-up, except for
recurrence in the liver three years later after resection.
Therefore, we diagnosed this tumor as a PHCT.
Surgical resection is the preferred treatment for PHCT
and has provided favorable outcomes. One study showed
that postoperative 1-, 5-, and 10-year survival rates were
88%, 80% and 68%, respectively [9]. Liver transplantation
has been reported in a small number of unresectable
patients. Studies showed that liver transplantation is a
feasible and affordable option in patients with unresect-
able PHCT that gives good long-term results for disease-
free survival [10]. Transcatheter arterial chemoemboliza-
tion has been reported to achieve good palliation in some
unresectable patients [11-13]. TACE was also effective
for the recurring tumor [14]. TACE is recommended for
cases with unresectable and/or recurrence tumors, but
the long-term survival is not usually good enough. The
recurrence rate of PHCT at 5 years after resection was as
high as 26% [15]. In our case, the recurrence was shown
three years after operation, and then TACE was per-
formed. Although the recurrence of PHCT was found,
surgical resection combination with TACE seemed effec-
tive to offer excellent palliation in the current case.
Conclusion
In summary, primary hepatic carcinoid tumor is a rare
tumor. The diagnosis of primary hepatic carcinoid
tumor is base on the histological examination and the
exclusion of metastasis disease. Surgical resection is the
preferred treatment. Transcatheter arterial chemoembo-
lization is effective to offer excellent palliation for the
multiple recurrence lesions.
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